NOVEL APPROACH FOR SOLUBILITY ENHANCEMENT OF MANGIFERIN
Main Article Content
Keywords
Abstract
The main intension of the present study is to enhance solubility and oral bioavailability of mangiferin naturally occurring bioactive compound having poor solubility by the different methods like kneading method and solvent evaporation method. The solid dispersions were made by using variety polymers like cross povidone, sodium starch glucolate, lecithin, β-cyclodextrin in ratios of 1:1, 1:2, 1:3,1:4 and 1:5. Phase solubility studies, Differential scanning calorimetry, X-Ray powder diffraction and fourier transform infrared spectroscopy were used to evaluate compatibility of mangiferin with selected polymers. Solid dispersions prepared by kneading method with sodium starch glycolate in 1:2 ratio shown maximum solubility of 791micrograms per ml (0.791mg/ml) compared with pure drug 57 µg/ml (0.057mg/ml). Therefore it is formulated as tablet by direct compression method. Physicochemical properties and invitro dissolution studies are conducted to characterise tablets. The prepared solid dispersion shown maximum 98.3% release in 1h.
Downloads
References
1. Agrawal, G. P., Maheshwari, R. K. and Mishra, P. (2022) ‘Solubility enhancementofcefixime trihydrate by solid dispersions using hydrotropic solubilization technique and their characterization’, Brazilian Journal of Pharmaceutical Sciences, 58. doi: 10.1590/s2175-97902020000118553. 2. Baán, A. et al. (2019) ‘Dry amorphisation of mangiferin, a poorly water-soluble compound, using mesoporous silica’, European Journal of Pharmaceutics and Biopharmaceutics, 141, pp. 172–179. doi: 10.1016/j.ejpb.2019.05.026. 3. Demeyer, S. et al. (2021) ‘Development of mangiferin loaded chitosan-silica hybrid scaffolds: Physicochemical and bioactivity characterization’, Carbohydrate Polymers, 261, p. 117905. doi: 10.1016/j.carbpol.2021.117905. 4. Jamil, R. and Polli, J. E. (2022a) ‘Prediction of in vitro drug dissolution into fasted-state biorelevant media: Contributions of solubility enhancement and relatively low colloid diffusivity’, European Journal of Pharmaceutical Sciences, 174, p. 106210. doi: 10.1016/j.ejps.2022.106210. 5.Jamil, R. and Polli, J. E. (2022b) ‘Prediction of In Vitro Drug Dissolution into Fed-state Biorelevant Media: Contributions of Solubility Enhancement and Relatively Low Colloid Diffusivity’, European Journal of Pharmaceutical Sciences, 173, p. 106179. doi: 10.1016/j.ejps.2022.106179. 6.Lee, J. Y. et al. (2022) ‘Enhancement of the water solubility and antioxidant capacities of mangiferin by transglucosylation using a cyclodextrin glycosyltransferase’, Enzyme and Microbial Technology, 159. doi: 10.1016/j.enzmictec.2022.110065. 7.Long, R. et al. (2021) ‘Unprecedented natural mangiferin excimer induced aggregation-induced emission luminogens for highly selective bioimaging of cancer cells’, Sensors and Actuators B: Chemical, 348, p. 130666. doi: 10.1016/j.snb.2021.130666. 8.Lum, P. T. et al. (2022) ‘Therapeutic potential of mangiferin against kidney disorders and its mechanism of action: A review’, Saudi Journal of Biological Sciences, 29(3), pp. 1530–1542. doi: 10.1016/j.sjbs.2021.11.016. 9.Mohana, M. and Vijayalakshmi, S. (2022) ‘Development and characterization of solid dispersion-based orodispersible tablets of cilnidipine’, Beni-Suef University Journal of Basic and Applied Sciences, 11(1), p. 83. doi: 10.1186/s43088-022-00259-3. 10.Navarro-Orcajada, S. et al. (2022) ‘The use of cyclodextrins as solubility enhancers in the ORAC method may cause interference in the measurement of antioxidant activity’, Talanta, 243, p. 123336. doi: 10.1016/j.talanta.2022.123336. 11.Nel, M., Samsodien, H. and Aucamp, M. E. (2022) ‘Using natural excipients to enhance the solubility of the poorly water-soluble antiretroviral, efavirenz’, Journal of Drug Delivery Science and Technology, 71, p. 103332. doi: 10.1016/j.jddst.2022.103332. 12.Sales, I. et al. (2022) ‘Selection of hydrotropes for enhancing the solubility of artemisinin in aqueous solutions’, Fluid Phase Equilibria, 562, p. 113556. doi: 10.1016/j.fluid.2022.113556. 13.Savjani, K. T., Gajjar, A. K. and Savjani, J. K. (2012) ‘Drug Solubility: Importance and Enhancement Techniques’, ISRN Pharmaceutics, 2012, pp. 1–10. doi: 10.5402/2012/195727. 14.Septiana, I. et al. (2020) ‘Enzymatic synthesis and biological characterization of a novel mangiferin glucoside’, Enzyme and Microbial Technology, 134, p. 109479. doi: 10.1016/j.enzmictec.2019.109479. 15.Thiengkaew, P. et al. (2021) ‘Response surface optimization of microfluidic formulations of nanobilosomes for enhancement of aqueous solubility, digestive stability, and cellular antioxidant activity of mangiferin’, Food Chemistry, 351, p. 129315. doi: 10.1016/j.foodchem.2021.129315. 16.Walia, V., Chaudhary, S. K. and Kumar Sethiya, N. (2021) ‘Therapeutic potential of mangiferin in the treatment of various neuropsychiatric and neurodegenerative disorders’, Neurochemistry International, 143, p. 104939. doi: 10.1016/j.neuint.2020.104939.
Article Sidebar
Article Details
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.